Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study
Hyun Cheol Chung, Esma Saada-Bouzid, Federico Longo, Eduardo Yanez, Seock Ah Im, Eduardo Castanon, Danielle N. Desautels, Donna M. Graham, Javier Garcia-Corbacho, Juanita Lopez, Corina Dutcus, Chinyere E. Okpara, Razi Ghori, Fan Jin, Roman Groisberg, Iphigenie Korakis
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 Study'. Together they form a unique fingerprint.